Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in...
Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non–small‐cell lung cancer
About this item
Full title
Author / Creator
Han, Rui , Zhang, Yimin , Wang, Tianhu , Xiao, Hualiang , Luo, Zhilin , Shen, Cheng , Li, Jianghua , Zhao, Chenglong , Li, Li , Zhu, Mengxiao , Du, Haiwei , Tang, Huan , Ma, Zheng , Wang, Yubo and He, Yong
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
The clinical outcome of resectable non–small‐cell lung cancer (NSCLC) patients receiving neoadjuvant chemoimmunotherapy is good but varies greatly. In addition, the pathological response after neoadjuvant chemoimmunotherapy is significantly associated with survival outcomes. The aim of this retrospective study was to identify which population of pa...
Alternative Titles
Full title
Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non–small‐cell lung cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10236616
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10236616
Other Identifiers
ISSN
1347-9032,1349-7006
E-ISSN
1349-7006
DOI
10.1111/cas.15778
